2023 Exhibitors

The AFSSI, the French Association of Service and Innovation Companies for the Life Sciences has the desire to unite French companies of services and technological innovation in the strategic field of Life Sciences.
These innovative companies evolve in the pre-clinical phases, but also clinical, constitute the force of our sector; dynamic and highly qualified actors, constituting a diversified fabric of scientific providers essential to the development of industries in the Life Science.

The Wallonia Export & Investment Agency (AWEX) is the institution in charge of the development and management of Wallonia’s domestic and international economic relations.
Through a personalized, innovative, and sustainable approach, AWEX supports Walloon companies – regardless of their size, sector, or target market – in every step of their inter- national endeavors. This includes exports, technological partnerships, and development abroad.

Alhena consult is a regulatory affairs consulting company providing advice on drug development and regulatory strategy while also offering project management services for Start-up in Europe.
Our mission is to guide you in the translational activities from research to development, in light of the regulatory pre-requisites. We help you to achieve your development goals from your lead candidate to your first in human study.

AnaPath Services (APS) based in Switzerland and AnaPath Research (APR) based in Spain are reputable CROs for Pharma, Biotech, (Agro)Chemical & MD companies. APR provides general toxicological studies, PK/PD, reproductive & developmental toxicology, veterinary products testing, bioanalytical services. APS is specialized in toxicologic pathology, histotechnology, necropsy, endocrine disruptor evaluation IHC, TCR, TEM, SEM, fetal & molecular pathology, material science.

AnyGenes® is a R&D biotechnology, totally owned by its founders.
Based on more than 15 years of experience, AnyGenes has three main activities: i) produces, manufactures and markets innovative and focused panel assays of signaling pathways, epigenetic (methylation analysis), microbiome and biomarkers profiling for translational medicine, ii) services for drug development by using our proprietary molecular platform, iii) development of multi-biomarkers clinical tests

APTSol offers equipment and services in the field of technological processes for obtaining solid particles and powders. The company manage three main technologies: spray drying, spray congealing and ionic gelation. It provides high value-added services for the development of new formulations, process optimization and scale-up testing, as well as innovative equipment for activities and small productions.

Artialis is a Belgian biotechnology company offering Preclinical, Clinical, and Biotesting services. Our mission is to accelerate the development of ATMP, drugs, medical devices, and food supplements by being your partener of choice from the development to the commercialization of your product. We are specialized in Musculoskeletal, inflammatory, gastrointestinal, nutrition, and age-related disorders.

Aseptic Technologies manufactures fill & finish equipment and devices for advanced pharmaceutical manufacturing. Our core expertise lays in the innovation of aseptic filling processes for biopharmaceutical products, including cell and gene therapy products.
As a member of SKAN Group, we leverage technological excellence of SKAN in the isolator design, providing integrated solutions for fill & finish projects, globally. We also offer customized ready-to-use cleanrooms assemblies .

Atlanpole Biotherapies is involved in the medicine of tomorrow, with innovative areas of focus for the development of new therapies and the discovery of unexplored methodologies for human treatments. The projects of network, both academic and industrial, show the excellence of our expertise in personalized medicine. It is a European Center Of Excellence in 4 domains :
– Biotechnology & Pharma
– MedTech
– Digital Health
– Disease prevention (One Health)

Atlantic Bone Screen is a French CRO providing non-GLP preclinical services.
We have a strong expertise in the field of osteoarticular indications / bone and joint diseases / biomaterials and in inflammation & oncology.
We have developed in vitro tests, in vivo animal models and other platforms such as imaging, histology and histopathology.
We support you to identify and characterize the therapeutic potential of your drug candidates, nutraceuticals and biomaterials.

Insurance broker which specialized in Life Sciences

BIOCentre provides laboratories and offices, conducts technical and business training and consultancy for start-ups and established companies active in the biotech, pharma, food and agrotech fields. BIOCentre connects companies, universities and scientific institutes. Central Laboratory’s units: Microbiology, Cell Biology, Downstream processing, Proteomics and Bioanalytical Chemistry are specialized to design the process optimization from biomass production up to a final biological product.

Established in 2009, BioElpida, a CDMO based in Lyon France , has continuously expanded its expertise and know-how in the development and GMP manufacturing of preclinical and clinical batches for start-ups and biotech companies engaged in innovative therapies.

Our team of experts address biotherapies projects from late discovery to clinical phase 3 by offering flexible and tailor-made approaches in compliance with the regulatory framework.  Our services also include cell banking and liquid aseptic fill & finish.

Biomapas is a premier CRO delivering flexible solutions globally throughout development as a seamless extension of your team.
We can enhance your Drug Development, accelerate your path to Market Authorization, and ensure compliance with local and global Post-Marketing requirements through a complete service scope in Clinical Research, Regulatory Affairs, Pharmacovigilance, and Medical Information.

bioPmed is the Piedmont innovation cluster dedicated to life science and health care. bioPmed since 2009 works to stimulate innovative activity by promoting collaboration, sharing of facilities and knowledge exchange. It combines over 90 companies, research centers, universities, foundations and service providers active in the fields of human health and life sciences, to promote the interaction between research and industry, stimulating innovation and accompanying internationalization processes.

Brussels South Charleroi BioPark is a campus that brings together a hundred players and 3300 people involved in the research, development and production of new therapies, medical devices and diagnostic methods.
We host subsidiaries of large international companies, SMEs from different countries, Belgian companies that are world leaders and three university research institutes from ULB and UMONS. This provides a rich environment in which to collaborate and grow businesses

The main objective of the Canceropole Sud is to gather and serve the academic, scientific, medical, and industrial community of Provence-Alpes-Côte d’Azur region working in the fight against cancer. Its aim is to accelerate cancer research in terms of benefits and improvement of outcomes for patients.

CARBOGEN AMCIS provides drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development. Our capabilities span from contract chemical process research and development to the supply of Active Pharmaceutical Ingredients (APIs) – as well as drug products for preclinical studies, clinical trials and commercial use. Besides being a service provider we also offer high quality Cholesterol and Vitamin D analog products.

Carnot France Futur Elevage is a french public research network, certified by the french ministry of research, that provides R&D competences to livestock farming sector businesses, including animal health, genetic selection, animal nutrition, socio-economic changes in the livestock industry, and livestock farming practices.
The main objectif of Carnot France Futur Elevage is to develop public-private partnership in order to support innovations for tomorrow’s sustainable breeding.

CER Groupe is an ISO/GLP-certified Belgian CRO (CIR certified) supporting human and veterinary health innovation through integrated and flexible bioproduction, non-clinical and analytical services meeting biotech, medtech, pharma, feed and food industries requirements. Our >200 collaborators are committed to offer best-in-class support to our partners, from discovery, hit to lead development and up to toxicity assessment, at the relevant quality standards (ISO9001, ISO17025 and GLP).

For over 70 years, Charles River has provided essential products and services to help pharmaceutical and biotechnology companies, government agencies, and academic institutions around the globe, helping to accelerate their research and drug development efforts. With over 90 sites globally, we’re ready to tackle your product’s most unique challenges. Our focus on timeliness and accuracy in every stage of drug development means you can count on us to deliver reliable results, every step of the way

Cherry Biotech, a biomedical tech (Organ on Chip) firm, develops instruments for drug discovery and personalized medicine. We aim to replace animal testing by cultivating human tissue (Organoids) in vitro for drug evaluation.
CubiX platform recreates immunocompetent human vascularized organ models and tumor microenvironments. This platform can uniquely transform a 2D multi-well plate into a 3D cell culture (Organ on Well), creating human 3D models mirroring physiology and pathophysiology.

CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases.

Ciloa, a French preclinical biotechnology company and spin-off from CNRS and University of Montpellier, is a pioneer in the field of exosomes bioengineered in vivo with membrane and/or cytosolic proteins to develop innovative preventive and therapeutic solutions. Ciloa provides unique expertise and tools to develop high-potential exosomes as a technology platform. Leading candidates (T2D, vaccines) at the regulatory-enabling stage are open for licensing, and more offers will be announced soon.

Clubster NHL – Nutrition, Health, Longevity – is a French competitiveness cluster federating 360 members in the Nutrition, biotechnology and health sectors. We foster collaboration between academia, private companies (start-up, SMEs and large companies), clinicians and final users. Our aim is to help our members to design, develop and finance their innovative products and processes. The activity encompasses the ONE HEALTH concept, close relation between human, animal and plant health.

CMD-COAT, a spin-off of the University of Liege (ULiege, BE), specializes in cardiovascular health research and bioactive coatings for medical devices. Founded in 2021 through collaboration between ULiege research centers and the Cardiology Department of the University Hospital of Liège, CMD-COAT developed the revolutionary COATI-X® coating technology allows for the simultaneous prevention of device-related thrombosis and infections, marking a significant advancement in medical device safety.

The CNCPI, or Compagnie Nationale des Conseils en Propriété Industrielle, is a legal entity instituted by law and codified in the French Intellectual Property Code.

The CNCPI represents French Patent & Trademark Attorneys whose core business is to guide companies in the protection, defence, and promotion of their intellectual property rights (e.g trademarks, patents, designs, software, databases, new technology rights, etc.)

The CNRS is a key player in innovation, both in France and worldwide. Finding applications for research results ensures that scientific advances benefit society, which is one of the missions entrusted by the French government to the CNRS.

Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface.

CrescendoCare offers unparalleled bioanalytical consultancy, targeted analysis, and expert development of diagnostic methods and kits through IVDR-compliant instruments With a focus on precision and innovation, the company specializes in targeted UPLC-MS/MS analysis for several biological samples, including mitochondria and PBMCs. Its extensive catalog covers a wide range of analytes, with specific applications in CardioRenal, Metabolic Inborn, Neuroscience, OncoHematology, and TDM.

Empower life-science research with Datamarkin, where creating personalized AI models is as simple as a few clicks. Our no-code platform transforms unique imagery into highly accurate, custom AI models, elevating analysis to new heights. Without AI expertise, train models specific to your needs, ensuring precision and tailored insights. Datamarkin makes advanced image analysis accessible, fostering innovation and discovery in every project.

DeepLab, an innovative SME, has recently established itself in life sciences, applying its extensive research & advanced AI capabilities to areas like drug discovery and precision medicine. Our key products include drug screening, lead optimization, target identification through interpretable models, cancer subtype classification, generative AI for synthetic bio data and wellness capable brain computer interfaces. We seek partners who aim to employ ML for drug discovery and (pre-)clinical cases.

DELTA 2000 srl is your local and worldwide RELIABLE partner. In design, production and installation of cleanrooms for environments with controlled contamination.
Founded from the fusion of two important companies, working in developing and manufacturing of cleanrooms. Today DELTA 2000 boasts an experience over 20 years in the pharmaceutical medical chemical food cosmetic electronic and architectural fields.
Innovation, high-quality products technology and development are keywords in DELTA 2000

DIVERSA, a biotech company, specializes in drug delivery using patented lipid nanoemulsions. We focus on meeting your molecule’s unmet needs, offering efficient formulations for drugs and biomolecules, including RNAs. Our technology, also applicable in dermocosmetics and nutraceuticals, supports collaborations towards clinical trials. We provide reagents for easy formulation and mechanistic studies with fluorescent tracking. Our goal is to improve patient care with innovative, nanoemulsion-based

DocCity, a real estate operator, is dedicated to create innovative environments for healthcare.

Over three years, 120 million euros were invested in securing 25,000 square meters of healthcare-dedicated space in France. In late 2024, a “Totem” site in Marseille’s 9th arrondissement will offer fully-equipped biomedical research labs, bio-production facilities, and biotherapy spaces. The real estate offering includes shared services and technical resources, fostering an innovative ecosystem with synergies in biotherapies.

DocCity actively engages in biotechnology events in France, partnering with Eurobiomed to support biotech companies.

Drugabilis supports early R&D projects by fast and rationally developing early formulations for in vivo studies (efficacy, PK, Tox) in any species, optimizing the crystal form of new drug candidates and characterizing the physicochemical profiles of research compounds.
With an experience of about 20 years and 250+ clients, Drugabilis contributes to a faster selection of robust “drugs candidates” that will be able to fast undergo regulatory preclinical development phases to reach clinical trials

Founded in 2013, the Efor Group has positioned itself in 10 years as the leading European player in Life Sciences consulting.
With more than 2000 employees in 19 offices in France, Belgium, Switzerland, and the USA, we leverage our expertise and methods to assist our clients in securing the market approval and maintenance of healthcare products in a constantly evolving technical and regulatory environment.

Ethypharm is a pharmaceutical company focused on CNS and Hospital injectables through direct sales, distribution and licenses.
Ethypharm is also offering CDMO services from formulation, clinical trials, till validation.
Sterile forms (Ampoule, PFS, Vials, Lyo) and conventional (complex solid dosage forms and orals), using conventional API, High potent and Controlled drugs with a great expertise in taste masking, pellets and orodispersible technologies.

EUROBIOMED is the catalyst of the health sector in Southern France. EUROBIOMED leads territorial initiatives, provides resources and offers solutions for businesses and research organizations. EUROBIOMED helps them to innovate, finance, develop and achieve their strategic and business objectives to ultimately improve life through innovations in health. EUROBIOMED tops European rankings in all stages of innovation. Together, the + 420 EUROBIOMED members are a driving force in regional development (with 390 projects, representing +1,5 billion Euros).

Eurofins ADME BIOANALYSES services: Small & Large Molecule Bioanalyses, Biomarkers & Metabolites, Method Development & Validation, ADME, PK/PD, Discovery, Pre-Clinical & Clinical, Topical Product Development.
Eurofins CDMO services: Preformulation, Formulation Development, DP Manufacturing, Clinical Trial Supply and Logistics, CMC/RA
Eurofins OPTIMED services: Protocol Development & Study Design, Regulatory Analysis / Submission, Site and Trial Monitoring & Management, Bioanalysis, Biometry

The Eurofins BioPharma Product Testing France laboratory network is a CRO that provides the pharmaceutical, biotechnology and medical device industries with analytical services, in accordance with regulations (EMA, FDA, ISO, etc.) and current GMP, GLP and Cofrac standards, for the development and marketing of human and veterinary (bio)drugs and medical devices.

EVOLY Consulting, a G.A.C. Group company, backed by Bpifrance, supports innovative businesses in leveraging funding mechanisms aligned with their R&D projects, covering everything from R&D tax incentives to national and European grant initiatives.

EVOSENS is a specialist in the integration of custom photonic systems, with two complementary activities:
– engineering, focused on the design and update of photonic systems. We have skills in optics, electronics, mechanics and IT. We develop solutions using softwares ZEMAX, SOLIDWORKS, ALTIUM.
– manufacturing, dedicated to prototyping and manufacturing customized solutions. We have high-end facilities: 60 m² cleanroom, optical laboratory, equipment such as wavefront analyzers, spectrometers..

ExAdEx-Innov develops an innovative and upscalable biotherapy for the treatment of obesity-associated chronic metabolic diseases in total therapeutic failure, such as NASH, as well as Type-2 diabetes and complex obesity forms not responding to treatments. The patented ExAdEx core technology also allows to derisk drug development through a unique R&D ex vivo platform of human adipose tissue mimicking pathological contexts to generate clinically-relevant data at preclinical stage.

France Biotech, founded in 1997, is an independent association that brings together the country’s leading innovative health companies. As a leader in health innovation and a privileged intermediary with public authorities in France and Europe, France Biotech’s mission is to support the development of this industry in France, by improving the tax, legal, regulatory and managerial environment in which these companies operate and by advocating for their recognition as a leading-edge industry.

Fujirebio is an R&D-driven company constantly developing new technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care.

Our main focus are the neurodegenerative diseases (CSF and plasma markers), infectious diseases and oncology.

Galenica is a Swedish pharmaceutical company with activities in drug delivery and pharmaceutical development. Galenica perform extensive development work including preformulation, analytical method development, formulation development and quality control on pharmaceutical products, including all common dosage forms. Galenica also support in manufacturing of clinical trial material from Phase I to Phase III as well as small scale commercial production.

Welcome to GammaOmics, your partner in advanced personalized medicine. Discover SCENITH™, our groundbreaking single-cell technology for immuno-metabolic profiling. It offers unique insights into cellular metabolism, crucial for research in immunology, oncology, and metabolic studies. Our innovative SCENITH Flow cytometry product and Metabolomic Panel enable precise, single-cell analysis, revolutionizing metabolic research. Benefit from our research service and ImmunoProfiling Platform.

GEM FORLAB provides analytical services for life science industry (Pharma and Medtech companies, start up and CRO); thanks to a multidisciplinary approach, we deliver fit-for-purpose solutions, in compliance with GLP & GCP principles, when required. Our mission is to give Customers support throughout the R&D processes (discovery, Preclinical and Clinical studies (phase I-III), allowing them to boost licensing opportunities and fulfill regulatory requirements.

ICARE, SPECIALIST IN HEALTHCARE PRODUCT SAFETY CONTROL.
For over 28 years, Groupe ICARE services have been bringing clients the assurance that their marketed device or product meets regulatory and normative requirements. Our teams guide you and share their expertise in all stages of the life cycle of health products thanks to the 5 Icare skills centers, from concept to control of production (Biocompatibility & toxicologie, laboratory testing, validation & qualification, formation & consulting).

CRO dedicated to solid state and crystallization processes of small molecules since 2006.
Our services are:
¤ Analytical characterizations: we are equipped with XRPD, DSC, TGA, DVS, FTIR, Laser PSD, IDR, … All analyses are available on toxic samples down to 50 ng/m3
¤ Solid state screenings: Polymorphs, salts, co-crystals. Properties investigations on stability, solubility, dissolution
¤ Crystallization processes: Development from scratch, optimization of existing process, trouble shooting

ICROM is an API CDMO specialized in development and GMP manufacturing of Active Ingredients; with over 50 years of experience, ICROM is the partner of choice for pharmaceutical outsourcing, able to provide a wide range of tailored services, custom development and custom manufacturing of NCEs, generic APIs, ‘high-tech’ and difficult to make molecules for complex formulations.

IKA laboratory technology offers a wide range of innovative equipment for numerous applications in research and development. IKA has gained a leading position in the world market with its innovative bioreactors, magnetic stirrers, mixers, overhead stirrers, shakers, homogenizers, mills, centrifuges, pipettes, and specially developed software for laboratory and analysis applications , as well as temperature control products such as circulators, baths and incubators.

As an innovative and dynamic CRO, InnoSer supports the preclinical pipeline from its facilities in Belgium and the Netherlands. Our in-depth expertise allows us to provide customized and streamlined early drug development options with well-characterized and near-patient research models. Our services are designed with personalized tailoring in mind, supported by innovative technical capabilities, and are executed in close collaboration with our partners.

Carnot STAR is composed of 9 research units in the field of Sport, Health and Well-being. We offer to industries a complete portfolio of scientific expertise and know-how to support them on multidisciplinary R&D and innovation projects.

Intravacc is an established independent CDMO with years of experience in developing and optimizing vaccines for infectious diseases and therapeutic vaccines, we have transferred our technology worldwide for vaccines against polio, measles, diphtheria, Hib, and influenza. Around 30% of childhood disease vaccines are based on our technology and knowhow. We offer a wide range of expertise for vaccine development, from concept to Phase I/II clinical studies, for customers around the world.

IODA Consulting is a consulting company with a recognized expertise for innovative companies for more than 20 years. We are beside companies at all stages of maturity, especially in healthcare.
We offer 3 kinds of high value services:
– Accountancy.
– Management of R&D tax credits :
– Funding research
More, our fifty people team integrates besides finance profiles engineers, PhDs, senior strategy consultants in innovation funding to define and drive their development plan at their side.

IPSOMEDIC and IPSOMEL develop innovative continuous flow processes.
Our aim is to provide sustainable solutions for the manufacture of pharmaceutical ingredients in Europe at a competitive cost. Based on our patents, a first manufacturing unit is under construction in France, and will provide access to a drug that is regularly out of stock. Our Aubagne site brings together experts in chem & biotech processes, PAT and data science. It includes R&D laboratories. Pilot units are being built.

KEDGE supports your Talent Management.
Every year, KEDGE welcomes more than 6,000 professionals looking to develop their career, train and strengthen specific skills. The School supports people with their development goals and companies with their ambitions to expand both in France and abroad, whether they are seeking a complete transformation or new areas of expertise.
Let’s talk about our tailored solutions dedicated for international groups ans SMEs during the Biofit 2023 in Marseille.

European project LEAP-BIO aims at bridging the gap between different European regions in licensing and partnering associated with early-stage assets, driving the growth of the small and medium biopharma companies and contributing to a more competitive European biopharma industry at a global level. It has developed an early-stage focused IP licensing digital platform for biopharma SMEs and startup companies that combines AI-powered digital tool and face-to-face partnering events on BioFIT.

Mabion is a fully integrated CDMO offering a wide range of services related to the development and production of protein-based biotherapeutics, including monoclonal antibodies and vaccine antigens. With 16 years’ of experience, Mabion offers end-to-end solutions covering all stages of biologic drug development, from early clone selection and small-scale production, through process scale-up, large-scale manufacturing and quality control to sterile fill&finish, bioanalytics and regulatory support.

Our mission is to be the premier source of animal models and related services for the preclinical research and development of human medicines, vaccines, medical devices, and other therapies, as well as for the clinical research and development of companion animal pharmaceuticals.
We hold ourselves to the highest standards of health and quality, and AAALAC accreditation serves to enhance our top commitment to animal care and welfare.

MediTox is a GLP-certified CRO having experience in variety of compounds and therapeutic areas, with an experts and associates teams capable to conduct a number of experiments in full compliance with GLP standards and with another international guidelines (EMA/ICH, VICH, OECD, US FDA, ISO10993), providing core range of nonclinical studies supporting phases I – III of clinical trials and/or registration of human & veterinary drugs, medical device, food/feed additives.

Traumatic spinal cord injury is a huge unmet need for which there is no therapeutic solution. Medjeduse develops a proprietary biomaterial (Chitosan form) as a neurosurgical medical implant to heal spinal cord injuries that cause locomotor and sensory loss. A proof of concept has been achieved in rat preclinical models. A larger animal study in pigs is ongoing before executing a first-in-human clinical trial

Micronit is a trusted leader in high-quality microfluidic solutions. Their specialized team empowers clients to bring innovative products to market in life science and healthcare with cutting-edge technology and personalized support. Founded in 1999, the company has extensive experience in developing and manufacturing high-quality products for customers worldwide. Micronit’s products are used in a variety of applications, including life science and healthcare.

Microsynth (founded in 1989) is a leading European company in nucleic acid synthesis & analysis. The main activities are divided into following three business areas:

DNA/RNA Synthesis
DNA/RNA Analysis and Sequencing
Contract Research/Outsourcing

MT-act is a preclinical stage CNRS spin-off biotech that devised MT-discover®, a unique discovery platform that generates small molecules to safely restore microtubule cytoskeleton function in age-related diseases. We successfully employed MT-discover® in the space of cardiology and now expect it to fuel additional programs in the CNS. At MT-act, we ambition to bring innovative drug products to the clinic as treatment for several chronic diseases to improve patient’s life.

NextPharma is a EU CDMO with 10 sites located in Europe. NextPharma provides services from early pharmaceutical development, clinical supplies, scale-up and process validation through to commercial manufacturing for a large range of dosage forms like tablets, capsules, granules, pellets, gels, creams, liquid solutions & suspensions, ophthalmics, incl. specific niche expertise such as high potent, hormone, controlled drugs, lipid based and modified release formulations (Soft and hard capsules)

Founded in 1976 and headquartered in Waltham, MA, Nova Biomedical is a world leader in the development and manufacture of whole blood analyzers, point-of-care and critical care analyzers, and cell culture monitoring analyzers for the biotechnology market.
Nova manufactures BioProfile® automated cell culture analyzers for rapid analysis of metabolites, pH, osmolarity, gases and cell density/viability for a wide range of cell culture applications.

NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility.

Op2Lysis is a French-Belgian biotech company developing innovative treatments for patients with cerebrovascular thrombotic diseases, including orphan drug indications. Looking to raise €5M EUR, to complete their €27M EUR Series A round. The proceeds will be to (i) complete a combined Phase 1/2 clinical study of their lead asset O2L-001 in patients with hemorrhagic stroke and (ii) develop pipeline, based on their unique NANOp2Lysis® platform, for other indications including ischemic stroke.

OZ Biosciences creates & markets specialized life science research reagents. The company expertise’s are in drug delivery systems, transfection reagents, transduction tools, mRNA production, magnetic -, lipid- & polymer-based nanoparticles. OZB conceives cutting-edge technologies such as transfection reagents for bio-production (protein & virus), viral enhancer for cell therapy engineering, mRNA & LNP custom services for nucleic acid therapy and vaccines.

Paras Biopharma (Biologics CDMO) Finland offers Biologics CDMO Services, Biologics/Biosimilar Technology Development & Scale-up, & co-development & licensing partnership opportunities of high-value Biologics. Our unique technologies (Diabrid®, Biomultifold®, Noblecleav® & Cytofold StructQuant®) facilitates high productivity & quality of biologics. With expertise in critical areas inc. development of complex proteins (early-stage – large scale) and of enzymes for medicinal & bioprocess purposes.

PCI provides a global service with localized focus, delivering over 200 protocols a year in over 100 countries, utilizing best-in-class technologies combined with our experienced and dedicated teams. Providing a seamless service, PCI supports the global supply of IMPs with pharmaceutical development, clinical drug product manufacturing, packaging, labeling, storage and distribution.

PHYLOGENE is a R&D and testing company which developed a platform using functional omics and bioinformatics for untargeted effects discovery to deliver mechanisms of action or biomarkers. Among these, metaproteomics is now very efficient to compare for example stool samples, quantify the over- and underexpression of proteins before data processing.
Also, our company characterize raw materials in terms of their identification/quantification of large molecules, proteins and nucleic acids.

We are an internationally recognized and long established global preclinical CRO (GLP accredited), providing preclinical services encompassing drug discovery, screening, and safety testing using standardized and innovative techniques. Our expertise spans various therapeutic domains like Pain, CNS, CV, Inflammation, Oncology, Metabolism and Dermatology. We provide in vitro, in vivo, ex vivo, histology, and bioanalytical services to assist pharmaceutical, biotech, academic, and non-profit sectors.

With over 5000 customer-centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecule APIs, dosage forms and biologics.

For 25 years, Provence Promotion has been the main contact for companies looking to INVEST IN PROVENCE. Our multicultural team of 23 experts facilitates the establishment of projects in key sectors such as health, biotechnologies and medical technologies, opening the doors of local ecosystems to French and foreign investors. As an economic development agency, we provide free, confidential guidance. Get in touch to realise your investment ambitions in Provence!

ReACT Therapeutics developed 5th-gen potent and selective inhibitors to target Breast Cancer Resistance Protein, a key treatment failure cause. Our globally protected lead compound extends the duration of drug effects in existing and new cancer drugs. We could impact across >40 known cancer drugs and >14 cancer indications. Our lead compound combined with irinotecan, a gold standard chemotherapy, has not only doubled irinotecan’s efficacy but also increased mouse survival by a factor of 5.

The SATT Network brings together 13 Technology Transfer Offices (TTOs) in France. SATTs are commited to foster economic development by providing companies with high-potential technological solutions stemming from French public research to improve their competitiveness. Local, trusted players, we are connected on a daily basis to over 150,000 researchers, and offer privileged access to innovations from public laboratories. We detect, evaluate, protect inventions and bring innovation to the market by entrusting them to an existing company or a future startup. We finance their technological development through an exclusive investment fund. With over 750 startups created, SATTs are the first-class local players in the French Government’s Deeptech Plan, operated by Bpifrance. With our nationwide network, we are strategic partners for companies seeking growth through innovation.

Rombio uses artificial intelligence to generate operational schedules, according to the company’s KPIs, resources and constraints, optimised while taking uncertainty into account. Managers can monitor and adapt operations, anticipating future resource requirements, simulating resource investments, …

Roowin S.A. is a French Contract Research Organization with 26 years of experience. Our core business is fine chemistry with high value, supporting our customers from early drug discovery process development (GLP quantities) through medium-scale GMP production (up to 30 kg) with strong CMC capabilities.
Roowin extended it footprint in the U.S.A opening Roowin Inc. the wholly owned subsidiary of Roowin S.A. in San Diego (CA, U.S.A) in 2022.

Secoya Technologies is an innovative solution-driven company with over 10 years of in-house expertise. Today we empower a faster time-to-market for your novel medicine thanks to the seamless scale up enabled by our equipment. Secoya Technologies has developed 3 innovative technologies, based on the principles of microfluidics, in the field of crystallization, emulsification and pervaporation. For each one of those, we provide ranges of robust intensified reactors affording enhanced productivity

Selvita is a preclinical CRO providing multidisciplinary support in resolving the unique challenges of research within the areas of drug discovery and drug development.
The company offers support at every stage of the early discovery phase up to the preclinical development. Selvita specializes in a variety of processes from in silico drug design and synthesis of a target-focused library, to complex preclinical in vitro and in vivo pharmacology, and structural biology.

The French association for animal health industry (SIMV) represents manufacturers and marketers (on the French market) of medicines and reagents for pets and for farm animals. In order to contribute to the competitiveness of its member companies, the SIMV defines its value creation through its trades:
Federating ;
Anticipating;
Advising/training/informing;
Being watchful;
Representing the positions of its members.

SLAS is a global professional society of academic, industry and government life sciences researchers coupled with developers and providers of laboratory automation technology. SLAS advances scientific innovation by providing education, collaboration and professional development that unites scientists across disciplines to transform research.
SLAS2024: Boston, 3-7 February — 6000 delegates, 350 exhibitors
SLAS Europe 2024: Barcelona 27-29 May — 1000 delegates, 125 exhibitors

SCT offers a disruptive and novel manufacturing process capable of increasing the production of innovative cell therapies, while boosting manufacturing yields and the quality of cultured cells. The improved performance of this link in the value chain is accompanied by a reduction in the associated production costs.

Spartners by Servier & BioLabs is on a mission to empower life science innovation in Paris-Saclay by creating a unique place for life science startups to test, develop and grow game changing ideas.
Spartners offers fully equipped laboratory and office spaces that are supported by an experienced, dedicated, technical team. Designed to build community, Spartners enables high-potential life science companies to work, collaborate and innovate in a setting perfectly suited to meet their needs.

Sterling Pharma Solutions is a global contract development and manufacturing organisation with 50+ years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry. Sterling specialises in handling challenging chemistries, and also offers Antibody Drug Conjugate development and manufacturing.

Sterling has six facilities across the UK, US and Ireland, employing 1,350+ people.

SYNCROSOME provides relevant disease models (in cardiology, CNS , gastroenterology, metabolic disorders and respiratory fields), cutting-edge techniques, specific biomarkers and comprehensive background of physiopathology to assist drug discovery companies in selecting their compounds.
SYNCROSOME has developed and validated so far more than 20 disease models, and our flexible and human sized organization can design and operate tailored in vivo experimental

Syngene International Ltd. is an innovation focused global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world.
For more details, visit www.syngeneintl.com

Tenshi Kaizen’s InstaPill Freeze Dried Oral Dispersible tablet technology is the ideal platform for patient centric medicines for patients with Dysphagia or for medicines on the move / rescue treatments. We have a proven taste-masking toolkit and commercial products marketed by partners in USA, Canada, EU, UK and Australia. We are a CDMO with a very flexible business model and low cost of development. Come to booth A10 to try a placebo tablet.

Trinity College Dublin, the University of Dublin has a proud tradition of performing world class research and translating this research excellence into solutions with global economic and social impact. Trinity is the top ranked university in Ireland. Using the QS methodology we are ranked 81st in the world and using the Times Higher Education World University Rankings methodology we are 146th in the world.

Created in 1993, Unither Pharmaceuticals is a French CDMO dedicated to health products and specialized in sterile single doses and non-sterile liquids. It supplies the main global markets from a unique industrial network of 8 factories spread across 4 continents – North America, South America, Europe and Asia – and an R&D center of expertise mainly on the formulation of ophthalmic products. Unither pharmaceuticals has a turnover of 500 million euros and a workforce of 2200 people.

VECT-HORUS designs and develops vectors to facilitate the targeted delivery of drugs or imaging agents into the brain and other organs.

By combining pharmaceutical agents to its vectors, VECT-HORUS enables their transport across the BBB, which significantly impedes brain delivery of most drugs. Proof of concept of the technology was demonstrated in animal models for different vectorized molecules, among them the endogenous neuropeptide neurotensin.

Founded in 2012, X’PROCHEM is a CRO (Contract Research Organization) specializied in chemical protein synthesis.

We design and produce therapeutic proteins for our pharmaceutical and biotech partners. We manufacture complex and highly customized proteins up to 400 amino acids (40 kDa) by using an automated process.

As the world’s leading animal health company, we are driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, we continue to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners. A Fortune 500 company, we generated revenue of $8.1 billion in 2022 with ~13,800 employees. For more, visit www.zoetis.com.